Bildkälla: Stockfoto

Annexin: Our Q2 Comment - Redeye

Redeye comments on today’s Q2 report from Annexin Pharmaceuticals and largely reiterate our view of the company.

Börsvärldens nyhetsbrev
ANNONSER